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Abstract
Background
Ischemia and reperfusion (I/R) causes tissue damage and intracellular calcium levels are a
factor of cell death. Sodium calcium exchanger (NCX) regulates calcium extrusion and Tri-
sulfated Disaccharide (TD) acts on NCX decreasing intracellular calcium through the inhibi-
tion of the exchange inhibitory peptide (XIP).
Objectives
The aims of this research are to evaluate TD effects in liver injury secondary to I/R in ani-
mals and in vitro action on cytosolic calcium of hepatocytes cultures under calcium
overload.
Methods
Wistar rats submitted to partial liver ischemia were divided in groups: Control: (n = 10): sur-
gical manipulation with no liver ischemia; Saline: (n = 15): rats receiving IV saline before
reperfusion; and TD: (n = 15): rats receiving IV TD before reperfusion. Four hours after
reperfusion, serum levels of AST, ALT, TNF-α, IL-6, and IL-10 were measured. Liver tissue
samples were collected for mitochondrial function and malondialdehyde (MDA) content.
Pulmonary vascular permeability and histologic parameters of liver were determined. TD
effect on cytosolic calcium was evaluated in BRL3A hepatic rat cell cultures stimulated by
thapsigargin pre and after treatment with TD.
Results
AST, ALT, cytokines, liver MDA, mitochondrial dysfunction and hepatic histologic injury
scores were less in TD group when compared to Saline Group (p<0.05) with no differences
PLOSONE | DOI:10.1371/journal.pone.0149630 February 22, 2016 1 / 13
a11111
OPEN ACCESS
Citation: Vasques ER, Cunha JEM, Coelho AMM,
Sampietre SN, Patzina RA, Abdo EE, et al. (2016)
Trisulfate Disaccharide Decreases Calcium Overload
and Protects Liver Injury Secondary to Liver
Ischemia/Reperfusion. PLoS ONE 11(2): e0149630.
doi:10.1371/journal.pone.0149630
Editor: Jordi Gracia-Sancho, IDIBAPS - Hospital
Clinic de Barcelona, SPAIN
Received: August 25, 2015
Accepted: February 3, 2016
Published: February 22, 2016
Copyright: © 2016 Vasques et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: These authors have no support or funding
to report.
Competing Interests: The authors have declared
that no competing interests exist.
in pulmonary vascular permeability. In culture cells, TD diminished the intracellular calcium
raise and prevented the calcium increase pre and after treatment with thapsigargin,
respectively.
Conclusion
TD decreases liver cell damage, preserves mitochondrial function and increases hepatic
tolerance to I/R injury by calcium extrusion in Ca2+ overload situations.
Introduction
Ischemia-reperfusion (I/R) injury remains a major problem in various clinical situations,
including trauma, shock, hemorrhage, liver resection, and transplantation [1, 2]. Current thera-
peutic procedures, such as ischemic pre or post conditioning and intermittent vascular occlu-
sion, can minimize but not prevent hepatic I/R injury [3–6]. Up to the present time, although
many compounds have been tested, only a few drugs have been shown to ameliorate or dimin-
ish liver I/R injury [7–8].
The pathophysiology of hepatic damage after I/R is not entirely understood, but the changes
in intracellular calcium behavior has emerged as an important mechanism in the development
of cell damage [9, 10]. It has been shown that inhibition of cellular calcium accumulation pre-
vents hepatic I/R damage [11]. Furthermore, expression of calcium-sensing receptors plays a
vital role in apoptosis induced by I/R injury [12] and a decrease in mitochondrial Ca2+ levels
are associated with decreased apoptosis and cellular changes [13]. In addition, inhibition of
intracellular calcium overloading effectively minimizes organ damage in models of liver I/R
[14]. The intracellular calcium concentration is controlled by the membrane sodium-calcium
exchanger (NCX), which decreases calcium by exchanging calcium for extracellular sodium.
An endogenous regulatory peptide named Exchange Inhibitor Peptide (XIP) modulates the
activity of NCX [15]. In contrast, the in vitro stimulation of lipid peroxidation in isolated rat
hepatocytes increases cytosolic calcium levels by the influx of extracellular calcium especially
in the absence of sodium. When sodium is added to the incubation medium, the influx of cal-
cium induced by lipid peroxidation diminishes, preventing cell death, this process being medi-
ated by NCX [16].
Trisulfated disaccharide (TD) affects NCX action in rabbit endothelial aortic cells by
decreasing intracellular calcium through the inhibition of XIP [17]. However, the TD effect in
the liver has never been previously investigated. Thus, the purposes of this study were to inves-
tigate the effects of the reduction of intracellular calcium concentration, determined by TD
administration, on the hepatic injury of rats submitted to liver I/R and to demonstrate TD
effect in vitro on hepatocyte cultures under calcium overload.
Materials and Methods
In vivo experiments
Animals. Forty adultmale Wistar rats weighing 250-300g housed in individual cages in a
12h dark-light controlled environment were used for the experimental protocol. Rats had free
access to standard rat chow and water. The experimental protocol was approved by the Ethics
Committee for Animal Research of the Medical School of São Paulo University (research pro-
tocol n.138/13 in 04/24/2013) and received humanized care according to the criteria outlined
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in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal
Resources, Commission on Life Sciences and National Research Council. National Academic
Press, Washington, D.C., 1996).
Experimental design. The animals were randomly submitted to the following experimen-
tal protocols:
Control Group (CONTR): 10 animals submitted to surgical liver manipulation with no hepatic
ischemia induction.
Saline Group (SAL): 15 animals submitted to hepatic ischemia for one hour that received 0.4
ml of saline solution (0.9% NaCl) injected via the dorsal penile vein 10 minutes before liver
reperfusion.
Trisulfated disaccharide Group (TD): 15 animals submitted to hepatic ischemia for one hour
that received 0.2 mg/kg of trisulfated disaccharide (UNIFESP, Molecular Biology Labora-
tory, São Paulo, Brazil) diluted in 0.4 ml of 0.9% NaCl, injected via the dorsal penile vein 10
minutes before liver reperfusion.
Surgical procedure. Animals were anesthetized intraperitoneally with 30mg/kg of keta-
mine hydrochloride (Cristália, São Paulo, Brazil), and 30 mg/kg of xylazine (Bayer, São Paulo,
Brazil), and kept under mechanical ventilation (Small Animal Ventilator model 683, Harvard
Apparatus, Holliston, MA, USA) at a frequency of 60 cycles per minute and a tidal volume of
0.08 ml/kg. Animal’s body temperature was monitored throughout the whole procedure by a
digital rectal thermometer (YSI Precision 4000A Thermometer, USA) and kept between 35
and 37°C through external heating by a halogen lamp (45 W and 127 V). The surgical proce-
dure was performed through a 4 cm laparotomy extending caudally from the xiphoid process
with dissection of the medium and lateral common hepatic pedicle in all the three experimental
groups. Partial liver ischemia (70% of liver parenchyma) was produced in the SAL and TD
groups for one hour by clamping the pedicles of the median and left lateral hepatic lobes. The
abdominal incision was closed and reopened after 60 min for clamp removal and liver reperfu-
sion [18].
Sample collection. At 4 h after reperfusion, the animals were re-anesthetized as described
previously and submitted to laparotomy for collection of blood and tissues according to the
study design. The 4-hour period after the reperfusion has been chosen based on the results of
several previous studies from our laboratory that could demonstrate a significant major hepatic
damage at this time period compared to more prolonged time observation periods [19, 20].
Blood was collected by transdiaphragmatic cardiac puncture for determinations of AST, ALT,
TNF-α, IL-6 and IL-10. Euthanasia was performed by transecting the abdominal aorta and
inferior vena cava. Liver tissue was removed and samples of the ischemic lobes were obtained
for assessments of mitochondrial oxidation and phosphorylation, malondialdehyde (MDA)
contents, and histologic analysis. Pulmonary vascular permeability was determined in lung tis-
sue by Evans blue (EB) dye extravasation.
Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels.
The extent of hepatocellular injury was evaluated by determination of serum AST and ALT lev-
els. Quantification of enzyme activities was performed by optimized ultraviolet method
(COBAS MIRA, Roche) and results expressed in U/L.
Liver mitochondrial oxidation and phosphorylation activities. Liver mitochondrial
function was studied in ischemic liver lobes separated after liver removal and immersed in
homogenization solution for mitochondrial extraction as described previously [21].
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Mitochondrial oxygen consumption (activated state, S3 and basal state, S4) was measured
polarographically [22] using a Gilson 5/6H Oxygraph (Gilson Medical Electronics, Inc., Mid-
dleton, WI) in a closed reaction vessel fitted with a Clark oxygen electrode (Yellow Springs
Instruments Co., Yellow Springs, OH) at 28°C, using succinate as respiratory substrate. The
ratio of oxygen consumption in the presence of ADP to that in the absence of ADP (respiratory
control rate, RCR) and the ADP/O ratio were calculated as indices of oxidative and phosphory-
lative mitochondrial functions. [23]
RCR = oxygen consumption in state 3 / oxygen consumption in state 4.
ADP/O = moles of ATP formed from ADP per atom of oxygen consumed.
Respiratory states 3 and 4 were measured and reported as nanogram atoms of oxygen per
milligram mitochondrial protein per minute. Mitochondria protein content was determined by
the method of Lowry et al [24].
Lipid peroxidation analysis. Malondialdehyde (MDA) formation was used as indicative
of the occurrence of lipid peroxidation in the tissues and was estimated as thiobarbituric acid-
reactive substances (TBARS). Liver tissues (100 mg/ml) were homogenized in 1.15% KCl buffer
and centrifuged at 14,000×g for 20 min. An aliquot of the supernatant was then added to a
reaction mixture consisting of 1.5 ml 0.8% thiobarbituric acid, 200 μl 8.1% (v/v) sodium dode-
cyl sulfate, 1.5 ml 20% acetic acid (pH 3.5), and 600 μl distilled water. The mixture was then
heated at 90°C for 45 min. After cooling to room temperature, samples were cleared by centri-
fugation (10,000×g for 10 min), and the absorbance was measured at 532 nm using malondial-
dehyde bis (dimethyl acetal) as external standard. The content of lipid peroxides was expressed
as nmol MDA per mg of protein [25].
Determination of inflammatory mediators. Serum levels of TNF-α, IL-6, and IL-10 were
determined by ELISA using commercial kits (Invitrogen, CA, USA).
Lung tissue microvascular permeability analysis. Lung microvascular permeability was
quantified by the Evans blue dye (EBD) extravasation technique as described previously [26].
The results are expressed as microgram of EBD per gram of dry weight tissue. Expression of
results as a function of dry weight avoids under evaluation due to edema formation.
Histologic analysis of the liver. Liver samples were fixed in 10% buffered formalin for
standard hematoxylin and eosin staining. Histologic evaluation of the liver sections was per-
formed by the same blinded pathologist. The severity of histologic injury was analyzed accord-
ing to the scoring system proposed by Quireze et al [27].
Trisulfated Dissacharide. Enzymes of adapted Flavobacterium heparinun degraded hepa-
rin and its degradation products were separated by combined Sephadex-gel filtration, paper
chromatography and chemically analysed. These products were identified as saturated disac-
charides constituted of uronic acid and glucosamine and containing three sulphate residues
with the same basic disaccharide units [28].
In vitro studies
Culture cells and TD. BRL3A culture cells from Rattusnorvegicus liver (cell line that
express NCX protein, the suggested target of TD) were grown in supplemented Dulbecco’s
modified Eagle’s medium for 24h [29]. Then, were loaded with the fluorescent Ca2+ indicator
fura-2/AM (4 μM) for 30 min at 25°C in a 5% CO2 atmosphere. Changes in cytosolic calcium
levels were measured kinetically at 37°C for 15 min. The ratio images were obtained using Cal-
cium Imaging mode in Leica Application Suite 3D Deconvolution & 3D Visualization software.
Thapsigargin (4 μM) was added to the culture medium to promote a sustained raise in the
cytosolic calcium level from endoplasmic reticulum. Calcium ionophore ionomycin (0.25 μM)
was used at the end of each experiment to reach the maximal increase in cytosolic calcium. To
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evaluate the TD effect on cytosolic calcium level, 30 μM of TD was added to the medium 120
seconds before and after the thapsigargin addition. The experiment was repeated for three
times under the same experimental conditions.
Statistical analysis. Results are presented as mean values ± SEM. Continuous variables were
compared using analysis of variance and post hoc testing with Tukey-Kramer multiple compari-
son test. Results from the histologic analysis were compared using the Kruskal-Wallis test and
Mann-Whitney’s test. The GraphPad 6 Prism Software (GraphPad Software, San Diego, CA)
was used for statistical analysis. The level of p<0.05 was considered as statistically significant.
Results
Animal experiments
There were no experimental animal deaths in the present study and all animals finished the
experiments successfully.
Hepatic enzymes (Serum AST and ALT). Four hours after reperfusion, serum levels of
both AST and ALT were significantly increased in the SAL and TD groups when compared to
the CONTR group. However, in the TD group AST and ALT serum levels were significantly
lower than in the SAL group (Fig 1A and 1B).
Liver mitochondrial oxidation and phosphorylation activities. Four hours after reperfu-
sion, there was a decrease in the oxygen consumption rate by liver mitochondria in state 3 (S3),
in respiratory control ratio (RCR), and in ADP/O ratio in the SAL group. This decrease was
not observed in TD and CONTR groups. No differences were found in state 4 (S4) between
SAL and TD groups (Fig 2A, 2B, 2C and 2D).
Liver MDA and lung permeability. At four hours after reperfusion, MDA content was
significantly increased in the ischemic liver in the SAL group. MDA content was also increased
in TD group but in a much lower extent, showing that TD significantly decreased the liver per-
oxidation induced by the I/R injury (Fig 3A). Lung microvascular permeability, as evaluated by
EBD extravasation, was increased 4 h after reperfusion in the SAL and TD groups compared to
the CONTR group, without significant difference between TD and SAL groups. (Fig 3B).
Inflammatory mediators. A significant increase in serum levels of TNF-α, IL-6, and IL-10
was observed in the SAL and TD group compared to the CONTR group. However, serum levels
of all three mediators were significantly lower in TD group when compared to the SAL group
(Fig 4A, 4B and 4C). As expected, TNF-αcould not be detected in the serum of animals from
CONTR group.
Liver histologic analysis. The histologic injury scores at 4 hours after liver reperfusion
was decreased in TD group compared to the SAL group. Additionally, liver cell necrosis was
significantly lower in the TD group when compared to the SAL group (Table 1 and Fig 5A, 5B
and 5C).
In vitro studies
Cytosolic calcium levels under TD action in liver cell cultures. Representative ratio
images of BRL3A cells loaded with fura-2 are presented in Fig 6, panel A, with a scale color
varying from blue (minimum) to pink (maximum). In panel B, the kinetics of the cytosolic cal-
cium variation of each sample is shown. As expected, the addition of 4 μM thapsigargin pro-
moted a sustained raise in the cytosolic calcium level in BRL3A liver cells (Fig 6, panel A). The
addition of TD to the culture medium after the thapsigargin-induced cytosolic calcium increase
transiently decreased intracellular calcium levels for about 250 seconds (Fig 6, panel B). In con-
trast, when TD was added prior to thapsigargin, just a slight decrease of intracellular calcium
basal level was observed. However, TD addition prior thapsigargin resulted in a lesser extend
Trisulfated Disaccharide in Liver Ischemia
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Fig 1. Aminotransferases four hours after liver reperfusion. 1A –AST—aspartate aminotransferase; 1B –ALT—alanine aminotransferase CONTR—
Control Group (n = 10); SAL—Saline Group (n = 15); TD—Trisulfated Disaccharide Group (n = 15). Data are expressed as mean values * (SAL vs TD and
SAL vs CONTR) p<0.05.
doi:10.1371/journal.pone.0149630.g001
Fig 2. Liver mitochondrial function. 2A –RCR—Respiratory control rate * (TD vs SAL) p<0.05; # (CONTR vs SAL) p<0,05; 2B—ADP/O—ADP/Oxygen
ratio * (SAL vs TD and SAL vs CONTR) p<0.05; 2C –S3—State 3 respiration * (SAL vs TD and SAL vs CONTR) p<0.05; 2D –S4—State 4 respiration NS: No
Significance. CONTR—Control Group (n = 10); SAL—Saline Group; TD (n = 15)—Trisulfated Disaccharide Group (n = 15). Data are expressed as mean
values.
doi:10.1371/journal.pone.0149630.g002
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Fig 3. Liver MDA and Lungmicrovascular permeability (EBD). 3A –Liver MDA. Data are expressed as mean values * (SAL vs TD and SAL vs CONTR)
p<0.05; 3B—Lung microvascular permeability (EBD) *(CONT vs SAL and CONTR vs TD) p<0.05. (TD vs SAL) NS. CONTR—Control Group; SAL (n = 10)–
Saline Group (n = 15); TD—Trisulfated Disaccharide Group (n = 15). NS: No Significance.
doi:10.1371/journal.pone.0149630.g003
Fig 4. Serum levels of inflammatory mediators. 4A—TNF-α; 4B—IL-6; 4C—IL-10 * (TD vs SAL) p<0.05; # (CONTR vs SAL) p<0.05. CONTR—Control
Group (n = 10); SAL—Saline Group (n = 15); TD—Trisulfated Disaccharide Group (n = 15). Data are expressed as mean values.
doi:10.1371/journal.pone.0149630.g004
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of cytosolic calcium increase determined by thapsigargin. These results show that TD was able
to decrease the intracellular calcium raise promoted by thapsigargin and to prevent it when
added prior to the inducer.
Discussion
Multiple clinical situations expose the liver to I/R injury. The pathogenesis of I/R damage is
multifactorial [30–32]. Altered cellular calcium handling is known to be of vital importance in
the I/R injury. Many investigators agree that modulation of cellular calcium homeostasis repre-
sents a key strategy for preventing I/R injury [33].
Heparin compounds have been studied in I/R injury. Heparin administration in high doses
has no beneficial effects and is associated with bleeding complications in liver and kidney
injury on the rat experimental model of I/R [34]. In contrast, protective effects of heparin were
demonstrated on hepatic I/R lesions in rabbits [35]. The heparin fragment Dalteparin reduces
I/R-induced liver injury in rats by attenuating the inflammatory response due to its capacity to
enhance endothelial production of prostacyclin via cyclooxygenase-1 activation, independently
of its anticoagulant activity [36]. N-desulfated heparin prevents hepatic/renal damage induced
by I/R injury without significant anticoagulant activity [37]. Enoxaparin has been shown to
decrease hepatic necrosis in a rat model of cholestatic liver injury, but this same effect was not
observed with heparin or tinzaparin [38]. The effect of different heparins on calcium extrusion
depends on the correlation between the fragments molecular weight and calcium modulation
[17]. Therefore, heparin compounds might be useful in liver protection but bleeding represents
a limiting factor in the eventual clinical use.
TD is the smallest heparin fragment, 585 Da weight, with no anticoagulant effect and higher
affinity to XIP than other heparin fragments [17]. It probably increases the activity of NCX in
the liver tissue by inhibition of XIP, thus accelerating calcium extrusion in situations of calcium
overload in a similar way as observed in muscle cell lines [17]. Therefore, it appears that XIP, a
part of NCX structure, is the target for the effect of TD in the toxic accumulation of calcium
that occurs during ischemia. Thus, it may have an eventual application in the clinical setting to
protect cells in calcium overload situations.
The present study, based on a model of partial warm hepatic I/R injury, showed that TD
pretreatment decreases hepatic I/R injury as evidenced by diminished AST and ALT levels as
well as by attenuated histopathological alterations. Furthermore, TD pre-treatment suppressed
the increases of inflammation serum markers (TNF-α, IL-6, IL-10) and hepatic lipid peroxida-
tion associated with hepatic lesion after I/R. In addition, mitochondrial function was preserved
under this situation. The protective mechanism involves the action of TD on intracellular cal-
cium extrusion, as demonstrated in the Fura-2 in vitro experiments, since TD was able to
decrease the intracellular calcium raise promoted by thapsigargin and to prevent it when added
prior to the inducer, suggesting a better protection in the pretreatment setting. These findings
Table 1. Liver histologic analysis.
Groups Liver Histologic Score Coagulation Necrosis Score
Control (n = 10) 0 (0–3) 0 (0–3)
Saline (n = 15) 9 (2–11) * 7.5 (0–9) *
TD (n = 15) 0 (0–5) 0 (0–3)
Data are presented as median and range TD—Trisulfated. Disaccharide * p<0.01 vs Control and TD
groups.
doi:10.1371/journal.pone.0149630.t001
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are in agreement with the results observed in vivo, when liver protection was observed when
TD infusion was performed 10 minutes before reperfusion.
In smooth muscle cell and, in other cell lines with NCX expression, TD decreases intracellu-
lar calcium in a dose-dependent manner via its binding to NCX [17]. In a human hepatoma
cell line, it was proposed that tert-butyl hydroperoxide induced apoptosis and increased intra-
cellular calcium concentration through the activation of an inhibitory mechanism on NCX
[39].
The Inflammatory cytokines TNF-α and IL-6 and, the anti-inflammatory IL-10 are released
after I/R injury [11]. Several reports indicate that Kupffer cells are activated during ischemia/
reperfusion injury increasing the production of cytokines and ROS [40, 41]. In the present
study, a significant decrease of serum levels of cytokines in the TD treated animals was
observed (Fig 4A, 4B and 4C). This may reflect a reduction of hepatic lesion after the ischemia/
reperfusion injury. However, other inflammatory triggers, such as damage-associated molecu-
lar patterns (DAMPs), that are released from necrotic cells, may also contribute to inflamma-
tion associated with hepatic ischemia-reperfusion injury [42,43]. Excessive ROS signaling leads
to cell death after I/R and, similarly to the ischemic accumulation of succinate, calcium also
participates in the reactions responsible for an extensive ROS generation [44, 45].
An anti-inflammatory effect of the low molecular weight heparin enoxaparin was described
on carbon tetrachloride induced hepatic necrosis and apoptosis in the liver of rats [46]. In the
present study, TD pretreatment also suppressed the increases of TNF-α, IL-6, and IL-10 serum
levels that occur after hepatic I/R, suggesting that modulation of the inflammatory response
could be another mechanism of TD liver protection. This anti-inflammatory effect appears to
be a local and immediate effect of TD since no distant benefit, as measured by pulmonary vas-
cular permeability, was obtained after the four-hour observation period in this study. The
decrease of IL-10 levels might be explained by the diminished cell damage determined by the
TD pretreatment.
Lipid peroxidation, as evaluated by MDA, is a mechanism of cell injury mediated by reactive
oxygen species (ROS). Both excessive ROS signaling and calcium overload lead to cell death
after I/R as calcium participates in the reactions that generate ROS [44, 45]. Our findings
showed that MDA levels in the ischemic liver lobe of TD pretreated animals were lower than
saline treated rats also suggesting a liver protective effect of TD. This observation is consistent
Fig 5. Liver histology. Liver cell necrosis was significantly lower in the TD group when compared to the SAL group. 5A– Control Group (n = 10); 5B –Saline
Group (n = 15); 5C –Trisulfated Disaccharide Group (n = 15).
doi:10.1371/journal.pone.0149630.g005
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Fig 6. TD effect on thapsigargin-induced cytosolic calcium increase in liver cells (n = 3). Panel A—Images of 340/380 nm fluorescence ratio using a
non-true color scale. Scale bars—50 μm; Time shown in white inside each frame; Panel B—Relative quantification of changes in calcium levels. Arrows
indicate additions. THAP—4 μM thapsigargin; IONO—0.25 μM ionomycin; TD—30 μM trisulfated disaccharide.
doi:10.1371/journal.pone.0149630.g006
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with the histologic observations that showed much less necrosis after I/R in the TD group. The
sustained increase in cytosolic calcium is commonly accompanied by mitochondrial calcium
uptake. Such increased mitochondrial calcium uptake results mitochondrial membrane per-
meabilization leading to caspase activation and disruption of multiple cellular functions [47].
Our assessment of mitochondrial function revealed the maintenance of oxygen consumption
rates in TD animal group comparable to the control group and higher than the saline group.
This mitochondrial protective effect of TD, also suggested by the histological findings, is possi-
bly related to calcium extrusion via NCX.
Animal models are frequently used to study possible pharmacological agents to attenuate I/
R in liver transplantation. A recent systematic search of the PubMed database for literature in
which pharmacological agents against I/R injury have been studied using rat liver transplant
models showed, by the results of a meta-analysis, that pharmacological treatment is effective to
reduce I/R liver damage in hepatic transplantation [48]. Based on the experimental data that
are available today, the authors propose that identified agents should be further evaluated in
human liver transplantation. Considering the findings of the present study TD represents a
promising agent that might be considered for evaluation in human liver protection. Although
this rat I/R model may not be completely translatable to human clinical characteristics of
hepatic I/R [49], it was purposely used in the present study with the intend of testing the even-
tual protective effect of TD under extreme liver damage conditions. In conclusion, the results
of this study demonstrate that trisulfated disaccharide pretreatment in a rat model of liver I/R
injury achieves hepatic protection, probably via modulation of intracellular calcium concentra-
tions mediated by Na-Ca exchanger. This hypothesis was demonstrated by the acceleration of
calcium extrusion and decrease of calcium levels in liver cell cultures pretreated with DT. More
data are necessary to further elucidate the mechanisms involved before its application in the
clinical setting is justified.
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